Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Far less is known about gray-market injectable peptides
Subcutaneous injections are commonly used for systemic benefits, while topical applications may target localized skin concerns
Despite initial pharmaceutical interest, AOD 9604 did not progress through the full clinical trial pathway required for regulatory approval, and it holds no Marketing Authorisation (MA) from the MHRA or EMA
It aids in the protection of cells from harm and contributes to the reinforcement of the immune system
Expect early surface improvements within a few weeks and firmer, smoother results over 8 to 12 weeks of consistent use
US$ 27.98
US$ 29.14
US$ 23.59
US$ 22.69
